Franklin Biotechnology Discovery A

Snapshot

Compare

Profile

Performance

FBDIX - Snapshot

Vitals

YTD Return 24.6%
3 Yr Annualized Return 9.3%
5 Yr Annualized Return 5.4%
Net Assets $1.34 B
Holdings in Top 10 43.9%

52 WEEK LOW AND HIGH

$183.45

$112.63

$188.06

Expenses

OPERATING RELATED FEES

Expense Ratio 1.03%

SALES FEES

Front Load 5.50%
Deferred Load N/A

BROKERAGE FEES

Turnover 32.92%

TRADING FEES

Max Redemption Fee N/A

Min Investment

Standard (Taxable) $1,000
IRA $250

Fund Classification

Primary Theme
Health Care Sector Equity
Fund Type Open End Mutual Fund
Investment Style Health

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Vanguard Health Care Fund

Fund

$222.74

+1.16%

$46.04 B

1.11%

$2.43

6.98%

Health Care Select Sector SPDR® Fund

XLV | ETF

$109.44

+0.92%

$22.44 B

1.52%

$1.65

7.74%

T. Rowe Price Health Sciences Fund

Fund

$100.53

+1.92%

$15.09 B

0.05%

$0.05

23.46%

Vanguard Health Care Index Fund

Fund

$107.45

+1.29%

$12.74 B

1.20%

$1.27

11.99%

Vanguard Health Care Index Fund

VHT | ETF

$215.00

+1.36%

$12.74 B

1.20%

$2.55

12.48%

FBDIX - Profile

Distributions

YTD Total Return 24.6%
3 Yr Annualized Total Return 7.3%
5 Yr Annualized Total Return 4.2%
Capital Gain Distribution Frequency Annually
Net Income Ratio -0.49%

DIVIDENDS

Dividend Yield 0.0%
Dividend Distribution Frequency Annually

Fund Details

Legal Name

Franklin Biotechnology Discovery Fund
Fund Family Name

Franklin Templeton Investments
Inception Date

Sep 15, 1997
Shares Outstanding

6362985
Share Class

A
Currency

USD
Domiciled Country

United States
Manager

Evan McCulloch

Fund Description

Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

FBDIX - Performance

Return Ranking - Trailing

Period	FBDIX Return	Category Return Low	Category Return High	Rank in Category (%)
YTD	24.6%	-4.9%	137.5%	19.88%
1 Yr	28.0%	-1.4%	132.6%	26.88%
3 Yr	9.3%*	0.8%	40.7%	73.43%
5 Yr	5.4%*	-0.7%	29.6%	83.57%
10 Yr	16.1%*	8.1%	19.7%	39.84%

* Annualized

Return Ranking - Calendar

Period	FBDIX Return	Category Return Low	Category Return High	Rank in Category (%)
2019	23.3%	3.8%	63.8%	31.03%
2018	-18.6%	-49.7%	21.5%	91.24%
2017	16.0%	-59.8%	54.4%	58.52%
2016	-20.7%	-36.6%	11.6%	78.29%
2015	-3.0%	-62.4%	27.9%	66.39%

Total Return Ranking - Trailing

Period	FBDIX Return	Category Return Low	Category Return High	Rank in Category (%)
YTD	24.6%	-4.9%	137.5%	19.88%
1 Yr	21.0%	-6.5%	132.6%	45.63%
3 Yr	7.3%*	-0.3%	40.7%	85.31%
5 Yr	4.2%*	-0.7%	29.6%	89.29%
10 Yr	15.4%*	8.1%	19.7%	46.34%

* Annualized

Total Return Ranking - Calendar

Period	FBDIX Return	Category Return Low	Category Return High	Rank in Category (%)
2019	23.3%	3.8%	63.8%	31.03%
2018	-18.6%	-25.3%	22.2%	92.70%
2017	18.8%	-10.8%	54.4%	61.48%
2016	-17.1%	-36.6%	11.6%	72.09%
2015	5.7%	-16.6%	27.9%	54.10%

NAV & Total Return History

FBDIX - Holdings

Concentration Analysis

	FBDIX	Category Low	Category High	FBDIX % Rank
Net Assets	1.34 B	3.74 M	46 B	41.28%
Number of Holdings	98	24	426	42.44%
Net Assets in Top 10	589 M	952 K	19.6 B	39.53%
Weighting of Top 10	43.94%	14.0%	75.7%	31.40%

Top 10 Holdings

Gilead Sciences Inc 6.39%
Regeneron Pharmaceuticals Inc 6.22%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%
Regeneron Pharmaceuticals Inc 6.06%

Asset Allocation

	Weighting	Return Low	Return High	FBDIX % Rank
Stocks	95.35%	61.47%	102.50%	82.56%
Cash	3.76%	-0.01%	32.46%	11.05%
Other	0.89%	-2.50%	6.07%	19.77%
Preferred Stocks	0.00%	0.00%	6.63%	20.93%
Convertible Bonds	0.00%	0.00%	0.06%	6.40%
Bonds	0.00%	0.00%	16.11%	8.72%

Stock Sector Breakdown

	Weighting	Return Low	Return High	FBDIX % Rank
Healthcare	98.79%	61.81%	100.00%	73.84%
Financial Services	1.21%	0.00%	3.31%	5.23%
Utilities	0.00%	0.00%	0.00%	5.23%
Technology	0.00%	0.00%	15.86%	18.60%
Real Estate	0.00%	0.00%	6.03%	11.05%
Industrials	0.00%	0.00%	5.94%	14.53%
Energy	0.00%	0.00%	0.00%	5.23%
Communication Services	0.00%	0.00%	4.69%	8.72%
Consumer Defense	0.00%	0.00%	34.31%	11.63%
Consumer Cyclical	0.00%	0.00%	1.09%	12.21%
Basic Materials	0.00%	0.00%	2.60%	34.88%

Stock Geographic Breakdown

	Weighting	Return Low	Return High	FBDIX % Rank
US	85.10%	47.91%	99.98%	35.47%
Non US	10.25%	0.00%	43.79%	68.60%

FBDIX - Expenses

Operational Fees

	FBDIX Fees (% of AUM)	Category Return Low	Category Return High	Rank in Category (%)
Expense Ratio	1.03%	0.08%	25.14%	51.81%
Management Fee	0.60%	0.00%	1.25%	34.30%
12b-1 Fee	0.25%	0.00%	1.00%	24.00%
Administrative Fee	0.15%	0.03%	0.40%	57.50%

Sales Fees

	FBDIX Fees (% of AUM)	Category Return Low	Category Return High	Rank in Category (%)
Front Load	5.50%	3.50%	5.75%	56.52%
Deferred Load	N/A	1.00%	5.00%	N/A

Trading Fees

	FBDIX Fees (% of AUM)	Category Return Low	Category Return High	Rank in Category (%)
Max Redemption Fee	N/A	1.00%	2.00%	N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

	FBDIX Fees (% of AUM)	Category Return Low	Category Return High	Rank in Category (%)
Turnover	32.92%	0.70%	252.00%	35.58%

FBDIX - Distributions

Dividend Yield Analysis

	FBDIX	Category Low	Category High	FBDIX % Rank
Dividend Yield	0.00%	0.00%	3.15%	19.77%

Dividend Distribution Analysis

	FBDIX	Category Low	Category High	Category Mod
Dividend Distribution Frequency	Annually	Annually	Annually	Annually

Net Income Ratio Analysis

	FBDIX	Category Low	Category High	FBDIX % Rank
Net Income Ratio	-0.49%	-2.53%	2.53%	79.04%

Capital Gain Distribution Analysis

	FBDIX	Category Low	Category High	Capital Mode
Capital Gain Distribution Frequency	Annually	Annually	Annually	Annually

Dividend Payout History

Date	Amount
Dec 19, 2016	$1.728
Dec 19, 2012	$0.069
Dec 30, 2011	$0.515

View More +

FBDIX - Fund Manager Analysis

Managers

Evan McCulloch

Start Date

Tenure

Tenure Rank

Sep 15, 1997

23.14

23.1%

Mr. McCulloch, CFA, joined Franklin Templeton Investments in 1992.

Wendy Lam

Start Date

Tenure

Tenure Rank

Sep 01, 2018

2.17

2.2%

Ms. Lam has joined Franklin Templeton Investments in 2016. Prior to joining Franklin Templeton, Ms. Lam was an Executive Director and Senior Analyst covering large-cap biotechnology for Oppenheimer & Co and had been an Equity Research Associate at Bank of America Merrill Lynch, Morgan Stanley and Oppenheimer & Co.

Akiva Felt

Start Date

Tenure

Tenure Rank

Jan 27, 2020

0.76

0.8%

Mr. Felt has been a portfolio manager, providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton in 2018. Prior to joining Franklin Templeton, Mr. Felt was a Senior Research Analyst with Asymmetry Capital, a healthcare focused hedge fund. He has covered the biotechnology sector since 2007 in increasing capacities on the sell-side, most recently as Managing Director for Oppenheimer & Co.

Tenure Analysis

Category Low	Category High	Category Average	Category Mode
0.09	23.14	7.28	20.52

You have successfully subscribed to Advisor Access. Thank you!

Franklin Biotechnology Discovery A

FBDIX - Snapshot

Vitals

52 WEEK LOW AND HIGH

Expenses

OPERATING RELATED FEES

SALES FEES

BROKERAGE FEES

TRADING FEES

Min Investment

Fund Classification

FBDIX - Profile

Distributions

Fund Details

Fund Description

FBDIX - Performance

Return Ranking - Trailing

Return Ranking - Calendar

Total Return Ranking - Trailing

Total Return Ranking - Calendar

NAV & Total Return History

FBDIX - Holdings

Concentration Analysis

Top 10 Holdings

Asset Allocation

Stock Sector Breakdown

Stock Geographic Breakdown

FBDIX - Expenses

Operational Fees

Sales Fees

Trading Fees

Related Fees

FBDIX - Distributions

Dividend Yield Analysis

Dividend Distribution Analysis

Net Income Ratio Analysis

Capital Gain Distribution Analysis

Dividend Payout History

FBDIX - Fund Manager Analysis

Managers

Evan McCulloch

Wendy Lam

Akiva Felt

Tenure Analysis

Advertisement

Wait! Do you know all the important aspects of mutual funds?

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access